BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kery M, Papandreou I. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes. Br J Radiol 2020;93:20200067. [PMID: 32462882 DOI: 10.1259/bjr.20200067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Aljanabi R, Alsous L, Sabbah DA, Gul HI, Gul M, Bardaweel SK. Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development. Molecules 2021;26:6019. [PMID: 34641563 DOI: 10.3390/molecules26196019] [Reference Citation Analysis]
2 Telarovic I, Wenger RH, Pruschy M. Interfering with Tumor Hypoxia for Radiotherapy Optimization. J Exp Clin Cancer Res 2021;40:197. [PMID: 34154610 DOI: 10.1186/s13046-021-02000-x] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
3 Matschke J, Larafa S, Jendrossek V. Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer? Biochem Soc Trans 2021;49:1265-77. [PMID: 34110407 DOI: 10.1042/BST20200866] [Reference Citation Analysis]
4 Qian C, Chen S, Li S, Wang Y, Yao J. Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis. Oncol Rep 2021;45:45. [PMID: 33649795 DOI: 10.3892/or.2021.7996] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Jeggo PA, Martin SG, Williams KJ, Prise KM. Advances in Radiation Biology - Highlights from the 16th ICRR special feature: introductory editorial. Br J Radiol 2020;93:20209006. [PMID: 33094649 DOI: 10.1259/bjr.20209006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]